BMRN
BioMarin Pharmaceutical Inc.
NASDAQHealthcareBiotechnologyUS
Rating:B+
Company Profile
CEO
Alexander Hardy
IPO Date
1999-07-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
BioMarin Pharmaceutical Inc.
CEO
Alexander Hardy
IPO Date
1999-07-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 7,490 |
| $0.00 |
| 4 Jun 2026 | Ho Maykin | director | A-Award | Acquired | 7,490 | $0.00 |
| 4 Jun 2026 | HOMBACH ROBERT J. | director | A-Award | Acquired | 7,490 | $0.00 |
| 4 Jun 2026 | Enyedy Mark J | director | A-Award | Acquired | 7,490 | $0.00 |
| 4 Jun 2026 | Dere Willard H | director | A-Award | Acquired | 7,490 | $0.00 |
| 4 Jun 2026 | CLARK IAN T | director | A-Award | Acquired | 7,490 | $0.00 |
| 4 Jun 2026 | Bodem Barbara W. | director | A-Award | Acquired | 7,490 | $0.00 |
| 4 Jun 2026 | ANDERSON ELIZABETH M | director | A-Award | Acquired | 7,490 | $0.00 |
| 21 May 2026 | Hubbard Cristin | EVP, Chief Commercial Officer | F-InKind | Disposed | 2,318 | $50.20 |
| 10 Jun 2022 | Ro Khanna | Ro Khanna | Sale | $1,001 - $15,000 |
| 15 Nov 2021 | Josh Gottheimer | Josh Gottheimer | Sale (Full) | $1,001 - $15,000 |
| 11 Jan 2021 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $15,001 - $50,000 |
| 5 Nov 2020 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 13 Oct 2020 | Josh Gottheimer | Josh Gottheimer | Sale (Full) | $1,001 - $15,000 |
| 6 Jan 2020 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 6 Jan 2020 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |